First-trimester maternal serum ADAM12-s and PAPP-A levels are altered in pregnancies conceived after assisted reproduction techniques (ART)

Prenatal Diagnosis

Volumn 36, Issue 2, 2016, Pages 163-169

  Sahraravand, Maarit ^a   Laitinen, Päivi ^b   Järvelä, Ilkka ^a   Ryynänen, Markku ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; ADAM12S PROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A; UNCLASSIFIED DRUG; ADAM12 PROTEIN; MEMBRANE PROTEIN; PAPPA1 PROTEIN, HUMAN;

ADULT; ARTICLE; CONCEPTION; CONTROLLED OVARIAN STIMULATION; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HORMONE SUBSTITUTION; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; MATERNAL SERUM; MENSTRUAL CYCLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ADOLESCENT; CASE CONTROL STUDY; CRYOPRESERVATION; IN VITRO FERTILIZATION; MATERNAL AGE; METABOLISM; MIDDLE AGED; OVULATION INDUCTION; PREGNANCY; YOUNG ADULT;

ADAM PROTEINS; ADAM12 PROTEIN; ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CRYOPRESERVATION; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMANS; MATERNAL AGE; MEMBRANE PROTEINS; MIDDLE AGED; OVULATION INDUCTION; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; REPRODUCTIVE TECHNIQUES, ASSISTED; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC; YOUNG ADULT;

EID: 84957812196     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4764     Document Type: Article

References (56)

1. Nicolaides K. Screening for fetal aneuploidies at 11 to 13weeks. Prenat Diagn 2011;31:7-15.
2. Bonduelle M, Van AE, Joris H, et al. Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters. Hum Reprod 2001;17:2600-14.
3. Gjerris AC, Loft A, Pinborg A, et al. Prenatal testing among women pregnant after assisted reproductive techniques in Denmark 1995-2000: a national cohort study. Hum Reprod 2008;23:1545-52.
4. Amor D, Xu JX, Halliday JL, et al. Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome. Hum Reprod 2009;24:1330-8.
5. Hennigsen AK, Pinborg A, Lidegaard O, et al. Perinatal outcome of singleton sibling born after assisted reproductive technology and spontaneous conception: Danish national sibling cohort study. Fertil Steril 2011;95:959-63.
6. Tabor A, Vestergaard CH, Lidegaard O. Fetal loss rate after chorionic villus sampling and amniocentesis: an 11-year national registry study. Ultrasound Obstet Gynecol 2009;34:19-24.
7. Geipel A, Gembruch U, Ludwig M, et al. Genetic sonography as the preferred option of prenatal diagnosis in patients with pregnancies following intracytoplasmic sperm injection. Hum Reprod 1999;14:2629-34.
8. Geipel A, Berg C, Katalinic A, et al. Different preferences for prenatal diagnosis in pregnancies following assisted reproduction versus spontaneous conception. Reprod Biomed Online 2004;8:119-24.
9. Barkai G, Goldman B, Ries L, et al. Down's syndrome screening marker levels following assisted reproduction. Prenat Diagn 1996;16:1111-4.
10. Ribbert LS, Komman LH, De Wolf BT, et al. Maternal serum screening for fetal Down syndrome in IVF pregnancies. Prenat Diagn 1996;16:35-8.
11. Frishman GN, Canick JA, Hogan JW, et al. Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies. Obstet Gynecol 1997;90:98-101.
12. Wald NJ, White N, Morris JK, et al. Serum markers for Down's syndrome in women who had in vitro fertilization: implications for antenatal screening. BJOG 1999;106:1304-6.
13. Raty R, Virtanen A, Koskinen P, et al. Serum free beta-hCG and alpha-fetoprotein levels in IVF, ICSI and frozen embryo transfer pregnancies in maternal mid-trimester serum screening for Down syndrome. Hum Reprod 2002;17:481-4.
14. Lambert-Messerlian G, Dugoff L, Vidaver J, et al. First- and second-trimester Down syndrome screening in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study. Prenat Diagn 2006;26:672-8.
15. Gilpin BJ, Loechel F, Mattei MG, et al. A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo. J Biol Chem 1998;273(1):157-66.
16. Laigaard J, Sørensen T, Fröhlich C, et al. ADAM12: a novel first-trimester maternal serum marker for Down syndrome. Prenat Diagn 2003;23:1008-13.
17. Spencer K, Cowans NJ, Stamatopoulou A. Maternal serum ADAM12s in the late first trimester of pregnancies in trisomy 21. Prenat Diagn 2008;28:422-4.
18. Valinen Y, Laitinen P, Ranta J, et al. Effect of a new marker, ADAM12, on Down risk figures in first trimester screening. J Matern Fetal Neonatal Med 2009;28:338-42.
19. Laigaard J, Cuckle H, Wewer UM, et al. Maternal serum ADAM12 levels in Down and Edwards' syndrome pregnancies at 9-12weeks' gestation. Prenat Diagn 2006;26:689-91.
20. Laigaard J, Spencer K, Christiansen M, et al. ADAM12 as a first-trimester maternal serum marker in screening for Down syndrome. Prenat Diagn 2006;26:973-9.
21. Spencer K. Screening for trisomy 21 in twin pregnancies in the first trimester using free beta-hCG and PAPP-A, combined with fetal nuchal translucency thickness. Prenat Diagn 2000;20:91-5.
22. Spencer K, Nicolaides KH. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years of experience. BJOG 2003;110:275-80.
23. Chasen ST, Perni SC, Kalish RB, et al. First trimester risk assessment for trisomies 21 and 18 in twin pregnancy. Am J Obstet Gynecol 2007;197:374.e1-3.
24. Spencer K, Kagan KO, Nicolaides KH. Screening for trisomy 21 in twin pregnancies in the first trimester: an update of the impact of chorionicity on maternal serum markers. Prenat Diagn 2008;28:49-52.
25. Laigaard J, Pedersen NG, Larsen SO, et al. ADAM12 in first trimester maternal serum from pregnancies conceived by assisted reproduction techniques. Prenat Diagn 2009;29:628-9.
26. Vilska S, Tiitinen A, Hyden-Granskog C, et al. Elective transfer of one embryo results in an acceptable pregnancy rate and eliminates the risk of multiple birth. Hum Reprod 1999;14:2392-5.
27. Tiitinen A, Halttunen M, Harkki P, et al. Elective single embryo transfer: the value of cryopreservation. Hum Reprod 2001;16:1140-4.
28. Martikainen H, Tiitinen A, Tomas C, et al. One versus two embryo transfer after IVF and ICSI: a randomized study. Hum Reprod 2001;16:1900-3.
29. Anckaert E, Schiettecatte J, Sleurs E, et al. First trimester screening for Down's syndrome after assisted reproductive technology: non-male factor infertility is associated with elevated free beta-human chorionic gonadotropin levels at 10-14weeks of gestation. Fertil Steril 2008;90:1206-10.
30. Gjerris AC, Loft A, Pinborg A, et al. First-trimester screening markers are altered in pregnancies conceived after IVF/ICSI. Ultrasound Obstet Gynecol 2009;33:8-17.
31. Bender F, Hecken J, Reisberg J, et al. Altered first-trimester screening markers after IVF/ICSI: no relationship with small-for-gestational-age and number of embryos transferred. Reprod Biomed Online 2010;20:516-22.
32. Engels MA, Kooij M, Schats R, et al. First-trimester serum marker distribution in singleton pregnancies conceived with assisted reproduction. Prenat Diagn 2010;30:372-7.
33. Bellver J, Casanova C, Garrido N, et al. Additive affect of factors related to assisted conception on the reduction of maternal serum pregnancy-associated plasma protein-A concentrations and the increases false-positive rates in first-trimester Down syndrome screening. Fertil Steril 2013;100:1314-20.
34. Liao A, Heath V, Kametas N, et al. First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod 2001;16:1501-4.
35. Tul N, Novak-Antolic Z. Serum PAPP-A levels at 10-14weeks of gestation are altered in women after assisted conception. Prenat Diagn 2006;26:1206-11.
36. Matilainen M, Peuhkurinen S, Laitinen P, et al. In combined first-trimester Down syndrome screening, the false-positive rate is not higher in pregnancies conceived after assisted reproduction compared with spontaneous pregnancies. Fertil Steril 2011;95:378-81.
37. Hui PW, Lam YH, Tang MH, et al. Maternal serum pregnancy-associated plasma protein-A and free beta-human chorionic gonadotrophin in pregnancies conceived with fresh and frozen-thawed embryos from in vitro fertilization and intracytoplasmic sperm injection. Prenat Diagn 2005;25:390-3.
38. Gowans NJ, Spencer K. Effect of gestational age on first trimester maternal serum prenatal screening correction factors for ethnicity and IVF conception. Prenat Diagn 2013;33:56-60.
39. Weisz B, Rodeck CH. An update on antenatal screening for Down's syndrome and specific implications for assisted reproduction pregnancies. Hum Reprod Update 2006;12:513-8.
40. Maymon R, Shulman A. Integrated first- and second-trimester Down syndrome screening test among unaffected IVF pregnancies. Prenat Diagn 2004;24:125-9.
41. Goetzinger KR, Cahill AG, Macones GA, et al. Association of first trimester low PAPP-A levels with preterm birth. Prenat Diagn 2010;30:309-13.
42. Yliniemi A, Nurkkala MM, Kopman S, et al. First trimester placental retinol-binding protein 4 (RBP4) and pregnancy-associated placental protein A (PAPP-A) in the prediction of early-onset severe pre-eclampsia. Metabolism 2015;64:521-6.
43. Spencer K, Staboulidou I, Nicolaides KH. First trimester aneuploidy screening in the presence of a vanishing twin: implications for maternal serum markers. Prenat Diagn 2010;30:235-40.
44. Bersinger NA, Wunder D, Vanderlick F, et al. Maternal serum levels of placental proteins after in vitro fertilisation and their implications for prenatal screening. Prenat Diagn 2004;24:471-7.
45. Ranta JK, Raatikainen K, Romppanen J, et al. Increased time-to-pregnancy and first trimester Down's syndrome screening. Hum Reprod 2010;25:412-7.
46. Maymon R, Shulman A. Serial first- and second-trimester Down syndrome screening test among unaffected IVF pregnancies. Prenat Diagn 2002;24:125-9.
47. Orlandi F, Rossi C, Allegra A, et al. First trimester screening with free beta-hCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction. Prenat Diagn 2002;22:718-21.
48. Bellver J, Lara C, Soares S, et al. First trimester screening for Down's syndrome in singleton pregnancies conceived by assisted reproduction. Hum Reprod 2005;20:2623-7.
49. Niemimaa M, Heinonen S, Hippelainen M, et al. First-trimester screening for Down's syndrome in in vitro fertilization pregnancies. Fertil Steril 2001;76:1282-3.
50. Ghisoni L, Ferrazzi E, Castagna C, et al. Prenatal diagnosis after ART success: the role of early combined screening tests in counseling pregnant patients. Placenta 2003;23:99-103.
51. Kagan K, Wright D, Spencer K, et al. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 2008;31:493-502.
52. Gjerris AC, Tabor A, Loft A, et al. First trimester prenatal screening among women pregnant after IVF/ICSI. Hum Reprod Update 2012;18:350-9.
53. Spencer K, Cowans NJ, Uldbjerg N, et al. First-trimester ADAM12s as early marker of trisomy 21: promise still unfulfilled? Prenat Diagn 2008;28:338-42.
54. Tørring N, Ball S, Wright D, et al. First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum marker. Reprod Biol Endocrinol 2010;8:129.
55. Valinen Y, Peuhkurinen S, Järvelä IY, et al. Maternal serum ADAM12 levels correlate with PAPP-A levels during the first trimester. Gynecol Obstet Invest 2010;70:60-3.
56. Spencer K, Vereecken A, Cowans NJ. Maternal serum ADAM12s as a potential marker of trisomy 21 prior to 10weeks of gestation. Prenat Diagn 2008;28:209-11.